Le Lézard
Classified in: Business
Subject: MAT

iAnthus Reports Second Quarter 2023 Financial Results


NEW YORK and TORONTO, Aug. 14, 2023 /CNW/ - iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTCPK: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results for the second  quarter ended June 30, 2023. The Company's Quarterly Report on Form 10-Q, which includes its unaudited interim condensed consolidated financial statements for the three and six months ended June 30, 2023 and the related management's discussion and analysis of financial condition and results of operations, can be accessed on the Securities and Exchange Commission's ("SEC's") website at www.sec.gov, the Company's SEDAR profile at www.sedar.com, and on the Company's website at www.iAnthus.com. The Company's financial statements are reported in accordance with U.S. generally accepted accounting principles ("GAAP"). All currency is expressed in U.S. dollars.

Second Quarter 2023 Financial Highlights

Table 1: Financial Results

in thousands of US$, except share and per share amounts (unaudited)


Q2 2023


Q1 2023


Q2 2022

Revenue

$

38,715

$

36,753

$

43,481

Gross profit


18,390


15,512


19,668

Gross margin


47.5 %


42.2 %


45.2 %

Net loss


(20,149)


(18,595)


(373,562)

Net loss per share


(0.00)


(0.00)


(0.65)

 

Table 2: Reconciliation of Net Loss to EBITDA and Adjusted EBITDA

in thousands of US$


Q2 2023


Q1 2023


Q2 2022

Net loss

$

(20,149)

$

(18,595)

$

(373,562)

Depreciation and amortization


6,809


6,991


7,394

Interest expense, net


3,895


3,731


5,777

Income tax expense


5,442


3,799


5,391

EBITDA (Non-GAAP) (6)

$

(4,003)

$

(4,074)

$

(355,000)

Adjustments







Write-downs and other charges, net


20


516


154

Inventory reserves and write-downs


-


356


177

Accretion expense


974


978


775

Share-based compensation (1)


1,593


1,489


21,372

Losses from change in fair value of financial instruments                              


11


33


138

Debt obligation fees (2)


-


-


390

Non-recurring charges (3)


1,092


529


18,218

Loss on debt extinguishment (4)


-


1,288


316,577

Other income (5)


(117)


(220)


(527)

Total Adjustments

$

3,573

$

4,969

$

357,274

Adjusted EBITDA (Non-GAAP) (6)

$

(430)

$

895

$

2,274

(1)  Represents ordinary share-based compensation expense for Q2 2023 and Q1 2023. Q2 2022 reflects a $21.0 million share-based compensation expense related to the graded vesting from the restricted stock units granted as a result of closing the Company's Recapitalization Transaction on June 24, 2022.

(2)  Reflects accrued interest on the exit fee owed to the holders of the Company's 13.0% senior secured convertible debentures. As the Company's Recapitalization Transaction closed on June 24, 2022, the Company will no longer incur debt obligation fees relating to such debentures.

(3)  Includes one-time, non-recurring costs related to the Company's Recapitalization Transaction, its strategic review process, ongoing legal disputes, and severance and other non-recurring costs associated with having become a U.S. reporting company. These non-recurring costs are offset by insurance proceeds received as reimbursement for certain legal costs incurred.

(4)  Q1 2023 reflects a one-time loss of $1.3 million on debt extinguishment related to the amendment of the $11.0 million senior secured bridge notes issued by iAnthus New Jersey, LLC. Q2 2022 reflects one-time loss of $316.6 million on debt extinguishment related to closing of the Company's Recapitalization Transaction.

(5)  Q2 2023 and Q1 2023 reflect approximately $0.1 million related to payroll tax refunds, and accounts payable write-offs of approximately $0.1 million. Q2 2022 reflects accounts payable write-offs of $0.3 million and payroll tax refunds of $0.2 million.

(6)  See "Non-GAAP Financial Information" below for more information regarding the Company's use of non-GAAP financial measures.

Non-GAAP Financial Information

This press release includes certain non-GAAP financial measures as defined by the SEC and the Canadian Securities Administrators. Reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are included in the tables above. This information should be considered as supplemental in nature and not as a substitute for, or superior to, any measure of performance prepared in accordance with GAAP.

In evaluating our business, we consider and use EBITDA as a supplemental measure of operating performance. We define EBITDA as earnings before interest, taxes, depreciation and amortization. We present EBITDA because we believe it is frequently used by securities analysts, investors and other interested parties as a measure of financial performance. We define Adjusted EBITDA as EBITDA before stock-based compensation, accretion expense, write-downs and impairments, gains and losses from changes in fair values of financial instruments, income or losses from equity-accounted investments, changes in accounting policy, non-recurring costs related to the Company's Recapitalization Transaction, and litigation costs related to ongoing legal proceedings.

EBITDA and Adjusted EBITDA are not standardized financial measures defined under GAAP, and are not a measure of operating income, operating performance or liquidity presented in accordance with GAAP. EBITDA and Adjusted EBITDA have limitations as an analytical tool, and when assessing the Company's operating performance, investors should not consider EBITDA or Adjusted EBITDA in isolation, or as a substitute for net income (loss) or other consolidated income statement data prepared in accordance with GAAP. Among other things, EBITDA and Adjusted EBITDA do not reflect the Company's actual cash expenditures. Other companies may calculate similar measures differently than us, limiting their usefulness as comparative tools. We compensate for these limitations by relying on GAAP results and using EBITDA and Adjusted EBITDA only as supplemental information.

About iAnthus

iAnthus owns and operates licensed cannabis cultivation, processing and dispensary facilities throughout the United States. For more information, visit www.iAnthus.com.

Forward Looking Statements

Statements in this press release contain forward-looking statements. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of management, are not guarantees of performance and are subject to significant risks and uncertainty. These forward-looking statements should, therefore, be considered in light of various important factors, including those set forth in the Company's reports that it files from time to time with the SEC and the Canadian securities regulators, which you should review including, but not limited to, the Annual Report filed with the SEC. When used in this press release, words such as "will," "could," "plan," "estimate", "expect", "intend", "may", "potential", "believe", "should" and similar expressions, identify forward-looking statements.

Forward-looking statements may include, without limitation, statements relating to the Company's financial performance, business development and results of operations.

These forward-looking statements should not be relied upon as predictions of future events, and the Company cannot assure you that the events or circumstances discussed or reflected in these statements will be achieved or will occur. If such forward-looking statements prove to be inaccurate, the inaccuracy may be material. You should not regard these statements as a representation or warranty by the Company or any other person that the Company will achieve its objectives and plans in any specified time frame, or at all. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any obligation to publicly update or release any revisions to these forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release or to reflect the occurrence of unanticipated events, except as required by law.

Neither the Canadian Securities Exchange nor the U.S. Securities and Exchange Commission has reviewed, approved or disapproved the content of this press release.

SOURCE iAnthus Capital Holdings, Inc.


These press releases may also interest you

at 04:04
Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration...

at 03:47
The 90th China International Medical Equipment Fair (CMEF) has successfully kicked off in Shenzhen, running from October 12-15. This year's event spans nearly 200,000 square meters and hosts nearly 4,000 exhibitors with an audience surpassing 200,000...

12 oct 2024
Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Winnebago Industries, Inc. resulting from allegations that Winnebago may have issued materially misleading business...

12 oct 2024
Eulerity, the industry-leading platform for multi-location marketing, just announced strategic partnerships with several prominent brands. Famous Brands International, the parent company of Mrs. Fields and TCBY, along with HealthSource Chiropractic,...

12 oct 2024
PackCapture has launched a new order packing recording system designed to enhance accuracy and efficiency in warehouse operations. With real-time recording, comprehensive analytics, and seamless integration with existing systems, PackCapture enables...

12 oct 2024
...



News published on and distributed by: